PATENT CLAIM ANALYSIS

Application Number: 16299675
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["424", "465000"]

Abstract:
The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.

Claim (Index 39):
The pharmaceutical composition of  claim 35 , wherein the glidant is colloidal silicon dioxide in an amount from 0.5 wt % to 3 wt %.

Metadata:
- Claim Count in Document: 92.0
- Percentile: 99.0
- Lexical Diversity: 1.39024
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15181114', '14286856', '15253636', '13942617', '15342999']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7617176232342641
- 35 USC 102 Novelty (BERT): 0.5461595373724807
- Combined Prediction Score: 0.7401618146480857
- Mean Citation Score: 325.633298
- Max Citation Score: 420.53372
- Similarity Product: 275.94998746089937

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test